Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 3

Completed

Conditions: Fallopian Tube Clear Cell Adenocarcinoma
Fallopian Tube Endometrioid Adenocarcinoma
Fallopian Tube Mucinous Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Fallopian Tube Transitional Cell Carcinoma
Malignant Ovarian Mixed Epithelial Tumor
Ovarian Brenner Tumor
Ovarian Clear Cell Adenocarcinoma
Ovarian Endometrioid Adenocarcinoma
Ovarian Mucinous Adenocarcinoma

Interventions: Biological: Bevacizumab
Other: Laboratory Biomarker Analysis
Drug: Carboplatin
Other: Placebo
Drug: Paclitaxel
Other: Quality-of-Life Assessment

Registration Number: NCT00262847

Lead Sponsor: National Cancer Institute (NCI)

Brief Summary: This randomized phase III trial studies carboplatin, paclitaxel, and bevacizumab to see how well they work compared to carboplatin, paclitaxel, and placebo in treating patients with stage III or stage IV ovarian epithelial, primary peritoneal, or fallopian tube cancer. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether carboplatin, paclitaxel, and bevacizumab are more effective than carboplatin, paclitaxel, and placebo in treating ovarian epithelial, primary peritoneal, or fallopian tube cancer.

Detailed Description: PRIMARY OBJECTIVE:

I. To determine if the addition of 5 concurrent cycles of bevacizumab to 6 cycles of standard therapy (carboplatin and paclitaxel) (Arm II) increases the duration of progression-free survival (PFS) when compared to 6 cycles of standard therapy alone (Arm I) in women with newly diagnosed stage III (with any gross residual disease) and stage IV, epithelial ovarian, peritoneal primary or fallopian tube cancer.

II. To determine if the addition of 5 concurrent cycles of bevacizumab plus extended bevacizumab for 16 cycles beyond the 6 cycles of standard therapy (carboplatin and paclitaxel) (Arm III) increases progression-free survival when compared to 6 cycles of standard therapy (Arm I) in women with newly diagnosed stage III (with any gross residual disease) and stage IV, epithelial ovarian, peritoneal primary or fallopian tube cancer.

SECONDARY OBJECTIVES:

I. In the event that both Arm II and Arm III regimens are superior to the Arm I regimen with respect to progression-free survival, to determine whether the Arm III regimen prolongs progression-free survival when compared to the Arm II regimen.

II. To determine whether the Arm II or Arm III regimen increases the duration of overall survival when compared with the Arm I regimen.

III. To compare each of the experimental regimens to the Arm I regimen with respect to the incidence of severe toxicities or serious adverse events.

IV. To determine the impact on Quality of Life (QOL, as measured by the Functional Assessment of Cancer Therapy-Ovarian \[FACT-O\] trial outcome index \[TOI\]) following treatment with the above regimens.

TERTIARY OBJECTIVES:

I. To assess the relationship between angiogenic markers and clinical outcome including tumor response, progression-free survival and overall survival in patients randomized to standard cytotoxic chemotherapy (paclitaxel and carboplatin) without bevacizumab, with concurrent bevacizumab or with extended bevacizumab.

II. To assess the predictive value of a set of genes whose expression correlates with survival of patients with stage III (with any gross residual disease) and stage IV, epithelial ovarian, peritoneal primary or fallopian tube cancer.

III. To bank whole blood for research. IV. To determine if genetic variations in genes associated with essential hypertension including WNK lysine deficient protein kinase 1 (WNK1), G protein-coupled receptor kinase 4 (GRK4) and kallikrein B (KLKB1) predict which patients are likely to develop bevacizumab-induced hypertension.

OUTLINE: Patients are randomized to 1 of 3 treatment arms.

ARM I: Patients receive paclitaxel intravenously (IV) over 3 hours and carboplatin IV over 30 minutes on day 1. Beginning in course 2, patients also receive placebo IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.

ARM II: Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.

ARM III: Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive bevacizumab alone IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Recruitment & Eligibility

Status: COMPLETED

Sex: Female

Target Recruitment: 1873

Inclusion Criteria

Patients with a histologic diagnosis of epithelial ovarian cancer, peritoneal primary carcinoma or fallopian tube cancer; International Federation of Gynecology and Obstetrics (FIGO) stage III with any gross (macroscopic or palpable) residual disease or FIGO stage IV, defined surgically at the completion of initial abdominal surgery and with appropriate tissue available for histologic evaluation; the minimum surgery required was an abdominal surgery providing tissue for histologic evaluation and establishing and documenting the primary site and stage, as well as a maximal effort at tumor debulking; if additional surgery was performed, it should have been in accordance with appropriate surgery for ovarian or peritoneal carcinoma described in the Gynecologic Oncology Group (GOG) Surgical Procedures Manual; however, the surgeon is not required to have performed all of the items contained in this section of the GOG Surgical Procedures Manual; those patients with stage III cancer in which the largest maximal diameter of any residual tumor implant at the completion of this initial surgery is no greater than 1 cm will be defined as "optimal;" all others will be defined as "suboptimal;" measurable disease on post-operative imaging studies is not required for eligibility
Patients with the following histologic epithelial cell types are eligible: serous adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, mixed epithelial carcinoma, transitional cell carcinoma, malignant Brenner's Tumor, or adenocarcinoma not otherwise specified (N.O.S.); however, the histologic features of the tumor must be compatible with a primary Müllerian epithelial adenocarcinoma; if doubt exists, it is recommended that the investigator should have the slides reviewed by an independent pathologist or, if necessary, the Pathology Co-Chair, prior to entry; patients may have co-existing fallopian tube carcinoma in-situ so long as the primary origin of invasive tumor is ovarian, peritoneal or fallopian tube
Absolute neutrophil count (ANC) greater than or equal to 1,500/µl equivalent to Common Toxicity Criteria for Adverse Events version (v)3.0 (CTCAE) grade 1; this ANC cannot have been induced or supported by granulocyte colony stimulating factors
Platelets greater than or equal to 100,000/µl; (CTCAE grade 0-1)
Creatinine =< 1.5 x institutional upper limit normal (ULN), CTCAE grade 1
Bilirubin less than or equal to 1.5 x ULN (CTCAE grade 1)
Serum glutamic oxaloacetic transaminase (SGOT) and alkaline phosphatase less than or equal to 2.5 x ULN (CTCAE grade 1)
Neuropathy (sensory and motor) less than or equal to CTCAE grade 1
Prothrombin time (PT) such that international normalized ratio (INR) is =< 1.5 (or an in-range INR, usually between 2 and 3, if a patient is on a stable dose of therapeutic warfarin for management of venous thrombosis including pulmonary thrombo-embolus) and a partial thromboplastin time (PTT) < 1.2 times the upper limit of normal
Patients with a GOG Performance Status of 0, 1, or 2
Patients must be entered between 1 and 12 weeks after initial surgery performed for the combined purpose of diagnosis, staging and cytoreduction
Patients with measurable and non-measurable disease are eligible; patients may or may not have cancer-related symptoms
Patients who have met the pre-entry requirements
An approved informed consent and authorization permitting release of personal health information must be signed by the patient or guardian
Patients in this trial may receive ovarian estrogen +/- progestin replacement therapy as indicated at the lowest effective dose(s) for control of menopausal symptoms at any time, but not progestins for management of anorexia while on protocol directed therapy or prior to disease progression

Exclusion Criteria

Patients with a current diagnosis of borderline epithelial ovarian tumor (formerly "tumors of low malignant potential") or recurrent invasive epithelial ovarian, primary peritoneal or fallopian tube cancer treated with surgery only (such as patients with stage Ia or Ib low grade epithelial ovarian or fallopian tube cancers) are not eligible; patients with a prior diagnosis of a borderline tumor that was surgically resected and who subsequently develop an unrelated, new invasive epithelial ovarian, peritoneal primary or fallopian tube cancer are eligible, provided that they have not received prior chemotherapy for any ovarian tumor
Patients who have received prior radiotherapy to any portion of the abdominal cavity or pelvis are excluded; prior radiation for localized cancer of the breast, head and neck, or skin is permitted, provided that it was completed more than three years prior to registration, and the patient remains free of recurrent or metastatic disease
Patients who have received prior chemotherapy for any abdominal or pelvic tumor including neo-adjuvant chemotherapy for their ovarian, primary peritoneal or fallopian tube cancer are excluded; patients may have received prior adjuvant chemotherapy for localized breast cancer, provided that it was completed more than three years prior to registration, and that the patient remains free of recurrent or metastatic disease
Patients who have received any targeted therapy (including but not limited to vaccines, antibodies, tyrosine kinase inhibitors) or hormonal therapy for management of their epithelial ovarian or peritoneal primary cancer
Patients with synchronous primary endometrial cancer, or a past history of primary endometrial cancer, are excluded, unless all of the following conditions are met: stage not greater than I-B; no more than superficial myometrial invasion, without vascular or lymphatic invasion; no poorly differentiated subtypes, including papillary serous, clear cell or other FIGO grade 3 lesions
With the exception of non-melanoma skin cancer and other specific malignancies as noted above, patients with other invasive malignancies who had (or have) any evidence of the other cancer present within the last five years or whose previous cancer treatment contraindicates this protocol therapy are excluded
Patients with acute hepatitis or active infection that requires parenteral antibiotics
Patients with serious non-healing wound, ulcer, or bone fracture; this includes history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 28 days; patients with granulating incisions healing by secondary intention with no evidence of fascial dehiscence or infection are eligible but require weekly wound examinations
Patients with active bleeding or pathologic conditions that carry high risk of bleeding, such as known bleeding disorder, coagulopathy, or tumor involving major vessels
Patients with history or evidence upon physical examination of central nervous system (CNS) disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within six months of the first date of treatment on this study
Patients with clinically significant cardiovascular disease; this includes:
Uncontrolled hypertension, defined as systolic > 150 mm Hg or diastolic > 90 mm Hg
Myocardial infarction or unstable angina < 6 months prior to registration
New York Heart Association (NYHA) grade II or greater congestive heart failure
Serious cardiac arrhythmia requiring medication; this does not include asymptomatic, atrial fibrillation with controlled ventricular rate
CTCAE grade 2 or greater peripheral vascular disease (at least brief (< 24 hrs) episodes of ischemia managed non-surgically and without permanent deficit)
History of CVA within six months
Patients with known hypersensitivity to Chinese hamster ovary cell products or other recombinant human or humanized antibodies
Patients with clinically significant proteinuria; urine protein should be screened by urine protein-creatinine ratio (UPCR); the UPCR has been found to correlate directly with the amount of protein excreted in a 24 hour urine collection; specifically, a UPCR of 1.0 is equivalent to 1.0 gram of protein in a 24 hour urine collection; obtain at least 4 ml of a random urine sample in a sterile container (does not have to be a 24 hour urine); send sample to lab with request for urine protein and creatinine levels [separate requests]; the lab will measure protein concentration (mg/dL) and creatinine concentration (mg/dL); the UPCR is derived as follows: protein concentration (mg/dL)/creatinine (mg/dL); patients must have a UPCR < 1.0 to allow participation in the study
Patients with or with anticipation of invasive procedures as defined below:
Major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to the first date of bevacizumab/placebo therapy (cycle 2)
Major surgical procedure anticipated during the course of the study; this includes, but is not limited to abdominal surgery (laparotomy or laparoscopy) prior to disease progression, such as colostomy or enterostomy reversal, interval or secondary cytoreductive surgery, or second look surgery; please consult with the study chair prior to patient entry for any questions related to the classification of surgical procedures
Core biopsy, within 7 days prior to the first date of bevacizumab/placebo therapy (cycle 2)
Patients with GOG Performance Grade of 3 or 4
Patients who are pregnant or nursing; bevacizumab should not be administered to nursing women; patients of childbearing potential must agree to use contraceptive measures during study therapy and for at least six months after completion of bevacizumab therapy
Patients who have received prior therapy with any anti-vascular endothelial growth factor (VEGF) drug, including bevacizumab
Patients with clinical symptoms or signs of gastrointestinal obstruction and who require parenteral hydration and/or nutrition
Patients with medical history or conditions not otherwise previously specified which in the opinion of the investigator should exclude participation in this study; the investigator should feel free to consult the study chair or study co-chairs for uncertainty in this regard

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Arm I (placebo, paclitaxel, carboplatin)	Laboratory Biomarker Analysis	Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Beginning in course 2, patients also receive placebo IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm I (placebo, paclitaxel, carboplatin)	Placebo	Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Beginning in course 2, patients also receive placebo IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm I (placebo, paclitaxel, carboplatin)	Quality-of-Life Assessment	Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Beginning in course 2, patients also receive placebo IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm II (placebo, paclitaxel, carboplatin, bevacizumab)	Bevacizumab	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm II (placebo, paclitaxel, carboplatin, bevacizumab)	Carboplatin	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm II (placebo, paclitaxel, carboplatin, bevacizumab)	Laboratory Biomarker Analysis	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm II (placebo, paclitaxel, carboplatin, bevacizumab)	Paclitaxel	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm II (placebo, paclitaxel, carboplatin, bevacizumab)	Placebo	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm II (placebo, paclitaxel, carboplatin, bevacizumab)	Quality-of-Life Assessment	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm III (paclitaxel, carboplatin, bevacizumab)	Bevacizumab	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive bevacizumab alone IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm III (paclitaxel, carboplatin, bevacizumab)	Laboratory Biomarker Analysis	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive bevacizumab alone IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm III (paclitaxel, carboplatin, bevacizumab)	Paclitaxel	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive bevacizumab alone IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm III (paclitaxel, carboplatin, bevacizumab)	Quality-of-Life Assessment	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive bevacizumab alone IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm I (placebo, paclitaxel, carboplatin)	Paclitaxel	Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Beginning in course 2, patients also receive placebo IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm I (placebo, paclitaxel, carboplatin)	Carboplatin	Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Beginning in course 2, patients also receive placebo IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive placebo alone IV over 30-90 minutes on day 1. Treatment with placebo repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.
Arm III (paclitaxel, carboplatin, bevacizumab)	Carboplatin	Patients receive paclitaxel and carboplatin as in arm I. Beginning in course 2, patients also receive bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days for 6 courses. Beginning in course 7, patients receive bevacizumab alone IV over 30-90 minutes on day 1. Treatment with bevacizumab repeats every 21 days for up to 22 courses in the absence of disease progression or unacceptable toxicity.

Primary Outcome Measures

Name	Time	Method
Progression-free Survival	From study entry until first disease progression, death or date of last contact, up to 6 years	Median progression-free survival (PFS). Onset of progression could be based on radiographic (RECIST) criteria or rising CA-125 (GCIG criteria).

Secondary Outcome Measures

Name	Time	Method
Overall Survival	From study entry to death or last contact, up to 6 years	Median overall survival (OS)
Frequency and Severity (Grade 3 or Above) of Adverse Events Assessed by Common Terminology Criteria for Adverse Events Version 3.0	Up to 5 years	Eligible and Evaluable patients
Impact on Quality of Life Measured by the Functional Assessment of Cancer Therapy-Ovary Trial Outcome Index (FACT-O TOI)	At baseline, 9, 18, 36, 60, and 84 weeks	Estimated least squares means from a mixed module of Quality of Life (QOL) scores at each assessment point, adjusted for baseline score and patient's age. Note: The range of possible scores of the FACT-O TOI is 0 - 104 for all treatment groups and at all visits. A higher score indicates better QOL. Baseline mean scores are raw means.

Trial Locations

Locations (625): Thomas Jefferson University Hospital
🇺🇸
Philadelphia, Pennsylvania, United States
Memorial Hospital at Easton - Shore Regional Cancer Center
🇺🇸
Easton, Maryland, United States
Cleveland Clinic Foundation
🇺🇸
Cleveland, Ohio, United States
Rush University Medical Center
🇺🇸
Chicago, Illinois, United States
University of Illinois
🇺🇸
Chicago, Illinois, United States
University of Chicago Comprehensive Cancer Center
🇺🇸
Chicago, Illinois, United States
UPMC-Magee Womens Hospital
🇺🇸
Pittsburgh, Pennsylvania, United States
John Muir Medical Center-Concord Campus
🇺🇸
Concord, California, United States
Banner Baywood Medical Center
🇺🇸
Mesa, Arizona, United States
East Bay Radiation Oncology Center
🇺🇸
Castro Valley, California, United States
Providence Saint Joseph Medical Center/Disney Family Cancer Center
🇺🇸
Burbank, California, United States
Northbay Cancer Center
🇺🇸
Fairfield, California, United States
Valley Medical Oncology Consultants-Castro Valley
🇺🇸
Castro Valley, California, United States
El Camino Hospital
🇺🇸
Mountain View, California, United States
Georgia Regents University Medical Center
🇺🇸
Augusta, Georgia, United States
Highland General Hospital
🇺🇸
Oakland, California, United States
Mount Sinai Medical Center
🇺🇸
New York, New York, United States
Boulder Community Hospital
🇺🇸
Boulder, Colorado, United States
Washington Hospital Center
🇺🇸
Washington, District of Columbia, United States
Contra Costa Regional Medical Center
🇺🇸
Martinez, California, United States
Long Beach Memorial Medical Center-Todd Cancer Institute
🇺🇸
Long Beach, California, United States
Kaiser Permanente Los Angeles Medical Center
🇺🇸
Los Angeles, California, United States
Tom K Lee Inc
🇺🇸
Oakland, California, United States
Kaiser Permanente-Oakland
🇺🇸
Oakland, California, United States
Sky Ridge Medical Center
🇺🇸
Lone Tree, Colorado, United States
McKee Medical Center
🇺🇸
Loveland, Colorado, United States
Stanford Cancer Institute
🇺🇸
Palo Alto, California, United States
Bay Area Tumor Institute
🇺🇸
Oakland, California, United States
Swedish Medical Center
🇺🇸
Englewood, Colorado, United States
Hartford Hospital
🇺🇸
Hartford, Connecticut, United States
Saint Mary's Hospital and Regional Medical Center
🇺🇸
Grand Junction, Colorado, United States
Valley Care Health System - Pleasanton
🇺🇸
Pleasanton, California, United States
Emory University/Winship Cancer Institute
🇺🇸
Atlanta, Georgia, United States
Manchester Memorial Hospital
🇺🇸
Manchester, Connecticut, United States
Mason District Hospital
🇺🇸
Havana, Illinois, United States
Proctor Hospital
🇺🇸
Peoria, Illinois, United States
Sarasota Memorial Hospital
🇺🇸
Sarasota, Florida, United States
Kewanee Hospital
🇺🇸
Kewanee, Illinois, United States
NorthShore University HealthSystem-Evanston Hospital
🇺🇸
Evanston, Illinois, United States
Florida Gynecologic Oncology
🇺🇸
Fort Myers, Florida, United States
Mount Sinai Hospital Medical Center
🇺🇸
Chicago, Illinois, United States
Morton Plant Hospital
🇺🇸
Clearwater, Florida, United States
Joliet Oncology-Hematology Associates Limited
🇺🇸
Joliet, Illinois, United States
Maui Memorial Medical Center
🇺🇸
Wailuku, Hawaii, United States
Central Georgia Gynecologic Oncology
🇺🇸
Macon, Georgia, United States
Elmhurst Memorial Hospital
🇺🇸
Elmhurst, Illinois, United States
Eureka Hospital
🇺🇸
Eureka, Illinois, United States
Northwestern University
🇺🇸
Chicago, Illinois, United States
Holy Cross Hospital
🇺🇸
Silver Spring, Maryland, United States
Porubcin, Michael MD (UIA Investigator)
🇺🇸
Moline, Illinois, United States
Pali Momi Medical Center
🇺🇸
'Aiea, Hawaii, United States
Florida Cancer Specialists-West Palm Beach
🇺🇸
West Palm Beach, Florida, United States
Illinois CancerCare-Ottawa Clinic
🇺🇸
Ottawa, Illinois, United States
Christiana Gynecologic Oncology LLC
🇺🇸
Newark, Delaware, United States
Beebe Medical Center
🇺🇸
Lewes, Delaware, United States
Lee Memorial Health System
🇺🇸
Fort Myers, Florida, United States
Presence Resurrection Medical Center
🇺🇸
Chicago, Illinois, United States
Saint Francis Hospital
🇺🇸
Federal Way, Washington, United States
Northwest Community Hospital
🇺🇸
Arlington Heights, Illinois, United States
Hopedale Medical Complex - Hospital
🇺🇸
Hopedale, Illinois, United States
Christiana Care Health System-Christiana Hospital
🇺🇸
Newark, Delaware, United States
The Hospital of Central Connecticut
🇺🇸
New Britain, Connecticut, United States
Pacific Cancer Institute of Maui
🇺🇸
Wailuku, Hawaii, United States
Ingalls Memorial Hospital
🇺🇸
Harvey, Illinois, United States
Northern Indiana Cancer Research Consortium CCOP
🇺🇸
South Bend, Indiana, United States
Rush - Copley Medical Center
🇺🇸
Aurora, Illinois, United States
Illinois CancerCare Galesburg
🇺🇸
Galesburg, Illinois, United States
Saint Luke's Mountain States Tumor Institute
🇺🇸
Boise, Idaho, United States
Perry Memorial Hospital
🇺🇸
Princeton, Illinois, United States
Memorial Hospital
🇺🇸
Carthage, Illinois, United States
Good Samaritan Regional Health Center
🇺🇸
Mount Vernon, Illinois, United States
Illinois CancerCare-Peoria
🇺🇸
Peoria, Illinois, United States
Covenant Medical Center
🇺🇸
Waterloo, Iowa, United States
University of Iowa/Holden Comprehensive Cancer Center
🇺🇸
Iowa City, Iowa, United States
Elkhart General Hospital
🇺🇸
Elkhart, Indiana, United States
Chicago Gynecologic Oncology SC
🇺🇸
Palatine, Illinois, United States
Franciscan Saint Anthony Health-Michigan City
🇺🇸
Michigan City, Indiana, United States
Mercy Medical Center-Sioux City
🇺🇸
Sioux City, Iowa, United States
South Bend Clinic
🇺🇸
South Bend, Indiana, United States
Greater Baltimore Medical Center
🇺🇸
Baltimore, Maryland, United States
McFarland Clinic PC-William R Bliss Cancer Center
🇺🇸
Ames, Iowa, United States
Community Cancer Center Foundation
🇺🇸
Normal, Illinois, United States
Cedar Rapids Oncology Association
🇺🇸
Cedar Rapids, Iowa, United States
Carle Clinic-Urbana Main
🇺🇸
Urbana, Illinois, United States
Memorial Medical Center
🇺🇸
Springfield, Illinois, United States
Saint Anthony Medical Center
🇺🇸
Rockford, Illinois, United States
Saint Margaret's Hospital
🇺🇸
Spring Valley, Illinois, United States
The Community Hospital
🇺🇸
Munster, Indiana, United States
Carle Cancer Center
🇺🇸
Urbana, Illinois, United States
Reid Hospital and Health Care Services
🇺🇸
Richmond, Indiana, United States
Providence Medical Center
🇺🇸
Kansas City, Kansas, United States
Medical Oncology and Hematology Associates-West Des Moines
🇺🇸
Clive, Iowa, United States
Illinois Valley Hospital
🇺🇸
Peru, Illinois, United States
Constantinou, Costas L MD (UIA Investigator)
🇺🇸
Bettendorf, Iowa, United States
Associates in Oncology Hematology PC -Kensington
🇺🇸
Kensington, Maryland, United States
Cancer Center of Kansas - Chanute
🇺🇸
Chanute, Kansas, United States
Eastern Maine Medical Center
🇺🇸
Bangor, Maine, United States
Christus Schumpert Saint Mary's Place
🇺🇸
Shreveport, Louisiana, United States
Cancer Center of Kansas-Kingman
🇺🇸
Kingman, Kansas, United States
Maine Medical Center-Bramhall Campus
🇺🇸
Portland, Maine, United States
Kaiser Permanente - Largo Medical Center
🇺🇸
Largo, Maryland, United States
Kaiser Permanente - Towson Medical Center
🇺🇸
Lutherville, Maryland, United States
MedStar Franklin Square Medical Center/Weinberg Cancer Institute
🇺🇸
Baltimore, Maryland, United States
Miller-Dwan Hospital
🇺🇸
Duluth, Minnesota, United States
Unity Hospital
🇺🇸
Fridley, Minnesota, United States
Mercy Health Mercy Campus
🇺🇸
Muskegon, Michigan, United States
Essentia Health Saint Mary's Medical Center
🇺🇸
Duluth, Minnesota, United States
Saint Francis Medical Center
🇺🇸
Cape Girardeau, Missouri, United States
Mercy Health Partners-Hackley Campus
🇺🇸
Muskegon, Michigan, United States
Saint Joseph Mercy Port Huron
🇺🇸
Port Huron, Michigan, United States
Fairview Ridges Hospital
🇺🇸
Burnsville, Minnesota, United States
Metro Health Hospital
🇺🇸
Wyoming, Michigan, United States
Toledo Clinic Cancer Centers-Monroe
🇺🇸
Monroe, Michigan, United States
Providence Hospital-Southfield Cancer Center
🇺🇸
Southfield, Michigan, United States
Frontier Cancer Center and Blood Institute-Billings
🇺🇸
Billings, Montana, United States
Center of Hope at Renown Medical Center
🇺🇸
Reno, Nevada, United States
Munson Medical Center
🇺🇸
Traverse City, Michigan, United States
Hackensack University Medical Center
🇺🇸
Hackensack, New Jersey, United States
Nebraska Cancer Research Center
🇺🇸
Lincoln, Nebraska, United States
Dartmouth Hitchcock Medical Center
🇺🇸
Lebanon, New Hampshire, United States
Saint Peter's Community Hospital
🇺🇸
Helena, Montana, United States
Big Sky Oncology
🇺🇸
Great Falls, Montana, United States
Frisbie Hospital
🇺🇸
Rochester, New Hampshire, United States
Renown Regional Medical Center
🇺🇸
Reno, Nevada, United States
Exeter Hospital
🇺🇸
Exeter, New Hampshire, United States
North Shore University Hospital
🇺🇸
Manhasset, New York, United States
Columbia University Medical Center
🇺🇸
New York, New York, United States
Saint Mary's Regional Medical Center
🇺🇸
Reno, Nevada, United States
Island Gynecologic Oncology
🇺🇸
Brightwaters, New York, United States
Gynecologic Oncology Network
🇺🇸
Greenville, North Carolina, United States
Case Western Reserve University
🇺🇸
Cleveland, Ohio, United States
Roswell Park Cancer Institute
🇺🇸
Buffalo, New York, United States
Akron General Medical Center
🇺🇸
Akron, Ohio, United States
Wilson Medical Center
🇺🇸
Wilson, North Carolina, United States
Laura and Issac Perlmutter Cancer Center at NYU Langone
🇺🇸
New York, New York, United States
Saint Joseph's Hospital Health Center
🇺🇸
Syracuse, New York, United States
Saint Alexius Medical Center
🇺🇸
Bismarck, North Dakota, United States
Orange Regional Medical Center
🇺🇸
Middletown, New York, United States
Long Island Jewish Medical Center
🇺🇸
New Hyde Park, New York, United States
New Hanover Regional Medical Center/Zimmer Cancer Center
🇺🇸
Wilmington, North Carolina, United States
Queens Hospital Center
🇺🇸
Jamaica, New York, United States
Randolph Hospital
🇺🇸
Asheboro, North Carolina, United States
Hope Women's Cancer Centers-Asheville
🇺🇸
Asheville, North Carolina, United States
North Shore-LIJ Health System/Center for Advanced Medicine
🇺🇸
New Hyde Park, New York, United States
Wayne Radiation Oncology
🇺🇸
Goldsboro, North Carolina, United States
State University of New York Upstate Medical University
🇺🇸
Syracuse, New York, United States
Kinston Medical Specialists PA
🇺🇸
Kinston, North Carolina, United States
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
🇺🇸
Maumee, Ohio, United States
FirstHealth of the Carolinas-Moore Regional Hosiptal
🇺🇸
Pinehurst, North Carolina, United States
Wayne Memorial Hospital
🇺🇸
Goldsboro, North Carolina, United States
Rutherford Hospital
🇺🇸
Rutherfordton, North Carolina, United States
Mid Dakota Clinic
🇺🇸
Bismarck, North Dakota, United States
Fredericksburg Oncology Inc
🇺🇸
Fredericksburg, Virginia, United States
Northern Virginia Pelvic Surgery Associates
🇺🇸
Annandale, Virginia, United States
Carilion Clinic Gynecological Oncology
🇺🇸
Roanoke, Virginia, United States
Saint Luke's Hospital
🇺🇸
Maumee, Ohio, United States
Saint Charles Hospital
🇺🇸
Oregon, Ohio, United States
Firelands Regional Medical Center
🇺🇸
Sandusky, Ohio, United States
Toledo Clinic Cancer Centers-Bowling Green
🇺🇸
Bowling Green, Ohio, United States
Hematology Oncology Center Incorporated
🇺🇸
Elyria, Ohio, United States
Lima Memorial Hospital
🇺🇸
Lima, Ohio, United States
Ohio State University Comprehensive Cancer Center
🇺🇸
Columbus, Ohio, United States
Atrium Medical Center-Middletown Regional Hospital
🇺🇸
Franklin, Ohio, United States
Blanchard Valley Hospital
🇺🇸
Findlay, Ohio, United States
Lake University Ireland Cancer Center
🇺🇸
Mentor, Ohio, United States
Mercy Hospital of Tiffin
🇺🇸
Tiffin, Ohio, United States
Sandra L Maxwell Cancer Center
🇺🇸
Cedar City, Utah, United States
University of Tennesee Health Science Center
🇺🇸
Memphis, Tennessee, United States
Reading Hospital
🇺🇸
West Reading, Pennsylvania, United States
East Tennessee State University
🇺🇸
Johnson City, Tennessee, United States
Logan Regional Hospital
🇺🇸
Logan, Utah, United States
Rappahannock General Hospital
🇺🇸
Kilmarnock, Virginia, United States
AnMed Health Hospital
🇺🇸
Anderson, South Carolina, United States
WellSpan Health-York Cancer Center
🇺🇸
York, Pennsylvania, United States
Greenville Health System Cancer Institute-Eastside
🇺🇸
Greenville, South Carolina, United States
Sanford Cancer Center-Oncology Clinic
🇺🇸
Sioux Falls, South Dakota, United States
Black Hills Obstetrics and Gynecology
🇺🇸
Rapid City, South Dakota, United States
University of Texas Medical Branch
🇺🇸
Galveston, Texas, United States
Women and Infants Hospital
🇺🇸
Providence, Rhode Island, United States
Cottonwood Hospital Medical Center
🇺🇸
Murray, Utah, United States
Lankenau Medical Center
🇺🇸
Wynnewood, Pennsylvania, United States
Mainline Health CCOP
🇺🇸
Wynnewood, Pennsylvania, United States
Dixie Medical Center Regional Cancer Center
🇺🇸
Saint George, Utah, United States
Danville Regional Medical Center
🇺🇸
Danville, Virginia, United States
American Fork Hospital
🇺🇸
American Fork, Utah, United States
Kaiser Permanente - Fair Oaks Medical Center
🇺🇸
Fairfax, Virginia, United States
Chattanooga Gynecological Oncology
🇺🇸
Chattanooga, Tennessee, United States
University of Virginia Cancer Center
🇺🇸
Charlottesville, Virginia, United States
Bon Secours Mary Immaculate Hospital
🇺🇸
Newport News, Virginia, United States
Providence - Saint Peter Hospital
🇺🇸
Olympia, Washington, United States
Saint Michael's Hospital
🇺🇸
Stevens Point, Wisconsin, United States
Virginia Oncology Associates - Lake Wright
🇺🇸
Norfolk, Virginia, United States
Welch Cancer Center
🇺🇸
Sheridan, Wyoming, United States
Vince Lombardi Cancer Clinic - Slinger
🇺🇸
Slinger, Wisconsin, United States
Marshfield Clinic
🇺🇸
Marshfield, Wisconsin, United States
Saint Joseph's Hospital
🇺🇸
Marshfield, Wisconsin, United States
Marshfield Clinic at James Beck Cancer Center
🇺🇸
Rhinelander, Wisconsin, United States
Marshfield Clinic-Minocqua Center
🇺🇸
Minocqua, Wisconsin, United States
Green Bay Oncology - Sturgeon Bay
🇺🇸
Sturgeon Bay, Wisconsin, United States
University of Washington Medical Center
🇺🇸
Seattle, Washington, United States
M D Anderson Cancer Center
🇺🇸
Houston, Texas, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center
🇺🇸
Miami, Florida, United States
Saint Vincent Hospital and Health Services
🇺🇸
Indianapolis, Indiana, United States
Kaiser Permanente-San Diego Mission
🇺🇸
San Diego, California, United States
University of Cincinnati
🇺🇸
Cincinnati, Ohio, United States
Kaiser Permanente San Leandro
🇺🇸
San Leandro, California, United States
Kaiser Permanente-San Francisco
🇺🇸
San Francisco, California, United States
UCSF Medical Center-Mount Zion
🇺🇸
San Francisco, California, United States
Vanderbilt University/Ingram Cancer Center
🇺🇸
Nashville, Tennessee, United States
Intermountain Health Care
🇺🇸
Salt Lake City, Utah, United States
Utah Cancer Specialists-Salt Lake City
🇺🇸
Salt Lake City, Utah, United States
Huntsman Cancer Institute/University of Utah
🇺🇸
Salt Lake City, Utah, United States
LDS Hospital
🇺🇸
Salt Lake City, Utah, United States
Shawnee Mission Medical Center-KCCC
🇺🇸
Shawnee Mission, Kansas, United States
Cancer Center of Kansas - Newton
🇺🇸
Newton, Kansas, United States
Radiation Oncology Practice Corporation Southwest
🇺🇸
Overland Park, Kansas, United States
University of Kansas Cancer Center
🇺🇸
Kansas City, Kansas, United States
Cancer Center of Kansas - Dodge City
🇺🇸
Dodge City, Kansas, United States
Cancer Center of Kansas - El Dorado
🇺🇸
El Dorado, Kansas, United States
Cancer Center of Kansas - Parsons
🇺🇸
Parsons, Kansas, United States
Cancer Center of Kansas - Salina
🇺🇸
Salina, Kansas, United States
Menorah Medical Center
🇺🇸
Overland Park, Kansas, United States
Cancer Center of Kansas-Independence
🇺🇸
Independence, Kansas, United States
Stormont-Vail Regional Health Center
🇺🇸
Topeka, Kansas, United States
Saint Francis Hospital and Medical Center - Topeka
🇺🇸
Topeka, Kansas, United States
Lawrence Memorial Hospital
🇺🇸
Lawrence, Kansas, United States
Graham Hospital Association
🇺🇸
Canton, Illinois, United States
Abington Memorial Hospital
🇺🇸
Abington, Pennsylvania, United States
Baystate Medical Center
🇺🇸
Springfield, Massachusetts, United States
Banner Good Samaritan Medical Center
🇺🇸
Phoenix, Arizona, United States
Saint John Hospital and Medical Center
🇺🇸
Detroit, Michigan, United States
University of Oklahoma Health Sciences Center
🇺🇸
Oklahoma City, Oklahoma, United States
University of Alabama at Birmingham Cancer Center
🇺🇸
Birmingham, Alabama, United States
Presbyterian - Saint Lukes Medical Center - Health One
🇺🇸
Denver, Colorado, United States
Rose Medical Center
🇺🇸
Denver, Colorado, United States
Colorado Cancer Research Program CCOP
🇺🇸
Denver, Colorado, United States
Legacy Good Samaritan Hospital and Medical Center
🇺🇸
Portland, Oregon, United States
Compass Oncology Rose Quarter
🇺🇸
Portland, Oregon, United States
Kaiser Permanente
🇺🇸
Portland, Oregon, United States
Oregon Health and Science University
🇺🇸
Portland, Oregon, United States
Bozeman Deaconess Hospital
🇺🇸
Bozeman, Montana, United States
Northern Montana Hospital
🇺🇸
Havre, Montana, United States
Kalispell Medical Oncology
🇺🇸
Kalispell, Montana, United States
Bozeman Deaconess Cancer Center
🇺🇸
Bozeman, Montana, United States
Mayo Clinic
🇺🇸
Rochester, Minnesota, United States
Kalispell Regional Medical Center
🇺🇸
Kalispell, Montana, United States
Community Medical Hospital
🇺🇸
Missoula, Montana, United States
Saint James Community Hospital and Cancer Treatment Center
🇺🇸
Butte, Montana, United States
Benefis Healthcare- Sletten Cancer Institute
🇺🇸
Great Falls, Montana, United States
Berdeaux, Donald MD (UIA Investigator)
🇺🇸
Great Falls, Montana, United States
Great Falls Clinic
🇺🇸
Great Falls, Montana, United States
Montana Cancer Specialists
🇺🇸
Missoula, Montana, United States
Saint Patrick Hospital - Community Hospital
🇺🇸
Missoula, Montana, United States
Fox Chase Cancer Center
🇺🇸
Philadelphia, Pennsylvania, United States
Meharry Medical College
🇺🇸
Nashville, Tennessee, United States
Missouri Valley Cancer Consortium
🇺🇸
Omaha, Nebraska, United States
Nebraska Methodist Hospital
🇺🇸
Omaha, Nebraska, United States
Alegent Health Immanuel Medical Center
🇺🇸
Omaha, Nebraska, United States
University of Nebraska Medical Center
🇺🇸
Omaha, Nebraska, United States
Froedtert and the Medical College of Wisconsin
🇺🇸
Milwaukee, Wisconsin, United States
Colorado Gynecologic Oncology Group
🇺🇸
Aurora, Colorado, United States
The Medical Center of Aurora
🇺🇸
Aurora, Colorado, United States
Stony Brook University Medical Center
🇺🇸
Stony Brook, New York, United States
University of Minnesota Medical Center-Fairview
🇺🇸
Minneapolis, Minnesota, United States
Exempla Saint Joseph Hospital
🇺🇸
Denver, Colorado, United States
Memorial Hospital Colorado Springs
🇺🇸
Colorado Springs, Colorado, United States
Saint Anthony Hospital
🇺🇸
Lakewood, Colorado, United States
Lakeland Hospital
🇺🇸
Saint Joseph, Michigan, United States
Genesys Regional Medical Center-West Flint Campus
🇺🇸
Flint, Michigan, United States
Saint John Macomb-Oakland Hospital
🇺🇸
Warren, Michigan, United States
Saint Jude Medical Center
🇺🇸
Fullerton, California, United States
Cancer Care Associates of Fresno Medical Group Inc
🇺🇸
Fresno, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center
🇺🇸
Orange, California, United States
Kaiser Permanente-Roseville
🇺🇸
Roseville, California, United States
Kaiser Permanente-Redwood City
🇺🇸
Redwood City, California, United States
Doctors Medical Center- JC Robinson Regional Cancer Center
🇺🇸
San Pablo, California, United States
Kaiser Permanente Medical Center - Santa Clara
🇺🇸
Santa Clara, California, United States
Santa Barbara Hematology Oncology Group Inc-Santa Barbara
🇺🇸
Santa Barbara, California, United States
Kaiser Permanente-Walnut Creek
🇺🇸
Walnut Creek, California, United States
Kaiser Permanente-Vallejo
🇺🇸
Vallejo, California, United States
John Muir Medical Center-Walnut Creek
🇺🇸
Walnut Creek, California, United States
West Penn Hospital
🇺🇸
Pittsburgh, Pennsylvania, United States
Genesis Medical Center - East Campus
🇺🇸
Davenport, Iowa, United States
Kaiser Permanente-Stockton
🇺🇸
Stockton, California, United States
Saint Francis Hospital and Medical Center
🇺🇸
Hartford, Connecticut, United States
Green Bay Oncology - Escanaba
🇺🇸
Escanaba, Michigan, United States
Cedars-Sinai Medical Center
🇺🇸
Los Angeles, California, United States
Saint Joseph Medical Center
🇺🇸
Tacoma, Washington, United States
Spectrum Health-Blodgett Campus
🇺🇸
Grand Rapids, Michigan, United States
Ridgeview Medical Center
🇺🇸
Waconia, Minnesota, United States
Hickman Cancer Center
🇺🇸
Adrian, Michigan, United States
Mercy Health Saint Mary's
🇺🇸
Grand Rapids, Michigan, United States
Holland Community Hospital
🇺🇸
Holland, Michigan, United States
Heartland Regional Medical Center
🇺🇸
Saint Joseph, Missouri, United States
Community Medical Center
🇺🇸
Toms River, New Jersey, United States
Monmouth Medical Center
🇺🇸
Long Branch, New Jersey, United States
Saint Louis University Hospital
🇺🇸
Saint Louis, Missouri, United States
Bryn Mawr Hospital
🇺🇸
Bryn Mawr, Pennsylvania, United States
Hackensack University Medical CCOP
🇺🇸
Hackensack, New Jersey, United States
Toledo Clinic Cancer Centers-Maumee
🇺🇸
Maumee, Ohio, United States
Overlook Hospital
🇺🇸
Summit, New Jersey, United States
Northern New Jersey CCOP
🇺🇸
Hackensack, New Jersey, United States
Morristown Medical Center
🇺🇸
Morristown, New Jersey, United States
Cone Health Cancer Center
🇺🇸
Greensboro, North Carolina, United States
MetroHealth Medical Center
🇺🇸
Cleveland, Ohio, United States
Scott and White Memorial Hospital
🇺🇸
Temple, Texas, United States
Lancaster General Hospital
🇺🇸
Lancaster, Pennsylvania, United States
Kettering Medical Center
🇺🇸
Kettering, Ohio, United States
Riddle Memorial Hospital
🇺🇸
Media, Pennsylvania, United States
Knoxville Gynecologic Cancer Specialists PC
🇺🇸
Knoxville, Tennessee, United States
Saint Clare Hospital
🇺🇸
Lakewood, Washington, United States
MultiCare Good Samaritan Hospital
🇺🇸
Puyallup, Washington, United States
MultiCare Allenmore Hospital
🇺🇸
Tacoma, Washington, United States
Multicare Health System
🇺🇸
Tacoma, Washington, United States
Northwest Medical Specialties PLLC
🇺🇸
Tacoma, Washington, United States
Holy Family Memorial Hospital
🇺🇸
Manitowoc, Wisconsin, United States
Seoul National University Hospital
🇰🇷
Seoul, Korea, Republic of
Waukesha Memorial Hospital
🇺🇸
Waukesha, Wisconsin, United States
Odette Cancer Centre- Sunnybrook Health Sciences Centre
🇨🇦
Toronto, Ontario, Canada
Marshfield Clinic - Wisconsin Rapids Center
🇺🇸
Wisconsin Rapids, Wisconsin, United States
Yongdong Severence Hospital
🇰🇷
Seoul, Korea, Republic of
Cancer Center of Santa Barbara
🇺🇸
Santa Barbara, California, United States
Rocky Mountain Gynecologic Oncology PC
🇺🇸
Englewood, Colorado, United States
Clearview Cancer Institute
🇺🇸
Huntsville, Alabama, United States
Banner Desert Medical Center
🇺🇸
Mesa, Arizona, United States
Northeast Alabama Regional Medical Center
🇺🇸
Anniston, Alabama, United States
Banner Thunderbird Medical Center
🇺🇸
Glendale, Arizona, United States
Mobile Infirmary Medical Center
🇺🇸
Mobile, Alabama, United States
Mayo Clinic in Arizona
🇺🇸
Scottsdale, Arizona, United States
Highlands Oncology Group PA - Fayetteville
🇺🇸
Fayetteville, Arkansas, United States
Washington Regional Medical Center - Fayetteville
🇺🇸
Fayetteville, Arkansas, United States
Western Regional CCOP
🇺🇸
Phoenix, Arizona, United States
Mercy Hospital Fort Smith
🇺🇸
Fort Smith, Arkansas, United States
University of Arkansas for Medical Sciences
🇺🇸
Little Rock, Arkansas, United States
Valley Medical Oncology Consultants-Fremont
🇺🇸
Fremont, California, United States
Eden Hospital Medical Center
🇺🇸
Castro Valley, California, United States
Kaiser Permanente-Fremont
🇺🇸
Fremont, California, United States
Bay Area Breast Surgeons Inc
🇺🇸
Emeryville, California, United States
Loma Linda University Medical Center
🇺🇸
Loma Linda, California, United States
UCLA / Jonsson Comprehensive Cancer Center
🇺🇸
Los Angeles, California, United States
Alta Bates Summit Medical Center - Summit Campus
🇺🇸
Oakland, California, United States
Hematology and Oncology Associates-Oakland
🇺🇸
Oakland, California, United States
Valley Medical Oncology Consultants
🇺🇸
Pleasanton, California, United States
Kaiser Permanente-Richmond
🇺🇸
Richmond, California, United States
Kaiser Permanente-San Rafael
🇺🇸
San Rafael, California, United States
Kaiser Permanente-Santa Rosa
🇺🇸
Santa Rosa, California, United States
Kaiser Permanente-South San Francisco
🇺🇸
South San Francisco, California, United States
Penrose-Saint Francis Healthcare
🇺🇸
Colorado Springs, Colorado, United States
Porter Adventist Hospital
🇺🇸
Denver, Colorado, United States
Poudre Valley Hospital
🇺🇸
Fort Collins, Colorado, United States
Front Range Cancer Specialists
🇺🇸
Fort Collins, Colorado, United States
North Colorado Medical Center
🇺🇸
Greeley, Colorado, United States
Exempla Lutheran Medical Center
🇺🇸
Wheat Ridge, Colorado, United States
Longmont United Hospital
🇺🇸
Longmont, Colorado, United States
Saint Mary Corwin Medical Center
🇺🇸
Pueblo, Colorado, United States
North Suburban Medical Center
🇺🇸
Thornton, Colorado, United States
Norwalk Hospital
🇺🇸
Norwalk, Connecticut, United States
Stamford Hospital/Bennett Cancer Center
🇺🇸
Stamford, Connecticut, United States
Saint Vincent's Medical Center
🇺🇸
Jacksonville, Florida, United States
Mayo Clinic in Florida
🇺🇸
Jacksonville, Florida, United States
Jupiter Medical Center
🇺🇸
Jupiter, Florida, United States
Bayfront Outpatient Health Clinic
🇺🇸
Saint Petersburg, Florida, United States
Grady Health System
🇺🇸
Atlanta, Georgia, United States
Phoebe Putney Memorial Hospital
🇺🇸
Albany, Georgia, United States
Northeast Georgia Medical Center
🇺🇸
Gainesville, Georgia, United States
Memorial University Medical Center
🇺🇸
Savannah, Georgia, United States
Saint Anthony's Health
🇺🇸
Alton, Illinois, United States
Swedish Covenant Hospital
🇺🇸
Chicago, Illinois, United States
Weiss Memorial Hospital
🇺🇸
Chicago, Illinois, United States
Decatur Memorial Hospital
🇺🇸
Decatur, Illinois, United States
Galesburg Cottage Hospital
🇺🇸
Galesburg, Illinois, United States
Mcdonough District Hospital
🇺🇸
Macomb, Illinois, United States
Loyola University Medical Center
🇺🇸
Maywood, Illinois, United States
Sharis, Christine M MD (UIA Investigator)
🇺🇸
Moline, Illinois, United States
Garneau, Stewart C MD (UIA Investigator)
🇺🇸
Moline, Illinois, United States
Stoffel, Thomas J MD (UIA Investigator)
🇺🇸
Moline, Illinois, United States
Bromenn Regional Medical Center
🇺🇸
Normal, Illinois, United States
Ottawa Regional Hospital and Healthcare Center
🇺🇸
Ottawa, Illinois, United States
Pekin Hospital
🇺🇸
Pekin, Illinois, United States
Advocate Lutheran General Hospital
🇺🇸
Park Ridge, Illinois, United States
Methodist Medical Center of Illinois
🇺🇸
Peoria, Illinois, United States
OSF Saint Francis Medical Center
🇺🇸
Peoria, Illinois, United States
Pekin Cancer Treatment Center
🇺🇸
Pekin, Illinois, United States
Fort Wayne Medical Oncology and Hematology Inc-Parkview
🇺🇸
Fort Wayne, Indiana, United States
Franciscan St. Francis Health-Beech Grove
🇺🇸
Beech Grove, Indiana, United States
IU Health La Porte Hospital
🇺🇸
La Porte, Indiana, United States
Indiana University/Melvin and Bren Simon Cancer Center
🇺🇸
Indianapolis, Indiana, United States
Saint Joseph Regional Medical Center-Mishawaka
🇺🇸
Mishawaka, Indiana, United States
Memorial Hospital of South Bend
🇺🇸
South Bend, Indiana, United States
Oncology Associates at Mercy Medical Center
🇺🇸
Cedar Rapids, Iowa, United States
Siouxland Regional Cancer Center
🇺🇸
Sioux City, Iowa, United States
Saint Luke's Regional Medical Center
🇺🇸
Sioux City, Iowa, United States
Cedar Valley Medical Specialists
🇺🇸
Waterloo, Iowa, United States
Johns Hopkins University/Sidney Kimmel Cancer Center
🇺🇸
Baltimore, Maryland, United States
The Memorial Hospital at Easton
🇺🇸
Easton, Maryland, United States
Union Hospital of Cecil County
🇺🇸
Elkton, Maryland, United States
Kaiser Permanente - Shady Grove Medical Center
🇺🇸
Rockville, Maryland, United States
Maryland Oncology Hematology PA-Aquilino Cancer Center
🇺🇸
Rockville, Maryland, United States
Commonwealth Hematology Oncology PC-Worcester
🇺🇸
Worcester, Massachusetts, United States
University of Massachusetts Medical School
🇺🇸
Worcester, Massachusetts, United States
Bixby Medical Center
🇺🇸
Adrian, Michigan, United States
Spectrum Health Big Rapids Hospital
🇺🇸
Big Rapids, Michigan, United States
Oakwood Hospital and Medical Center
🇺🇸
Dearborn, Michigan, United States
Bronson Battle Creek
🇺🇸
Battle Creek, Michigan, United States
Wayne State University/Karmanos Cancer Institute
🇺🇸
Detroit, Michigan, United States
Hurley Medical Center
🇺🇸
Flint, Michigan, United States
Grand Rapids Clinical Oncology Program
🇺🇸
Grand Rapids, Michigan, United States
Spectrum Health at Butterworth Campus
🇺🇸
Grand Rapids, Michigan, United States
Green Bay Oncology - Iron Mountain
🇺🇸
Iron Mountain, Michigan, United States
Gynecologic Oncology of West Michigan PLLC
🇺🇸
Grand Rapids, Michigan, United States
Allegiance Health
🇺🇸
Jackson, Michigan, United States
Borgess Medical Center
🇺🇸
Kalamazoo, Michigan, United States
Sparrow Hospital
🇺🇸
Lansing, Michigan, United States
West Michigan Cancer Center
🇺🇸
Kalamazoo, Michigan, United States
Bronson Methodist Hospital
🇺🇸
Kalamazoo, Michigan, United States
Saint Mary Mercy Hospital
🇺🇸
Livonia, Michigan, United States
McLaren-Northern Michigan
🇺🇸
Petoskey, Michigan, United States
Saint Joseph Mercy Oakland
🇺🇸
Pontiac, Michigan, United States
Mercy Memorial Hospital
🇺🇸
Monroe, Michigan, United States
Saint Mary's of Michigan
🇺🇸
Saginaw, Michigan, United States
William Beaumont Hospital-Royal Oak
🇺🇸
Royal Oak, Michigan, United States
Essentia Health Cancer Center
🇺🇸
Duluth, Minnesota, United States
Fairview-Southdale Hospital
🇺🇸
Edina, Minnesota, United States
Minnesota Oncology Hematology PA-Maplewood
🇺🇸
Maplewood, Minnesota, United States
Abbott-Northwestern Hospital
🇺🇸
Minneapolis, Minnesota, United States
Hubert H Humphrey Cancer Center
🇺🇸
Robbinsdale, Minnesota, United States
North Memorial Medical Health Center
🇺🇸
Robbinsdale, Minnesota, United States
Park Nicollet Clinic - Saint Louis Park
🇺🇸
Saint Louis Park, Minnesota, United States
Metro-Minnesota NCI Community Oncology Research Program
🇺🇸
Saint Louis Park, Minnesota, United States
United Hospital
🇺🇸
Saint Paul, Minnesota, United States
Saint Francis Regional Medical Center
🇺🇸
Shakopee, Minnesota, United States
Minnesota Oncology and Hematology PA-Woodbury
🇺🇸
Woodbury, Minnesota, United States
Singing River Hospital
🇺🇸
Pascagoula, Mississippi, United States
Saint Dominic-Jackson Memorial Hospital
🇺🇸
Jackson, Mississippi, United States
Southeast Missouri Hospital
🇺🇸
Cape Girardeau, Missouri, United States
University of Missouri - Ellis Fischel
🇺🇸
Columbia, Missouri, United States
Centerpoint Medical Center LLC
🇺🇸
Independence, Missouri, United States
Capital Regional Medical Center
🇺🇸
Jefferson City, Missouri, United States
North Kansas City Hospital
🇺🇸
Kansas City, Missouri, United States
Liberty Hospital
🇺🇸
Liberty, Missouri, United States
Liberty Radiation Oncology Center
🇺🇸
Liberty, Missouri, United States
Center for Cancer Care and Research
🇺🇸
Saint Louis, Missouri, United States
Washington University School of Medicine
🇺🇸
Saint Louis, Missouri, United States
Saint Louis Cancer and Breast Institute-South City
🇺🇸
Saint Louis, Missouri, United States
Missouri Baptist Medical Center
🇺🇸
Saint Louis, Missouri, United States
Mercy Hospital Saint Louis
🇺🇸
Saint Louis, Missouri, United States
Cancer Research for the Ozarks NCORP
🇺🇸
Springfield, Missouri, United States
Saint Louis-Cape Girardeau CCOP
🇺🇸
Saint Louis, Missouri, United States
Mercy Hospital Springfield
🇺🇸
Springfield, Missouri, United States
Montana Cancer Consortium CCOP
🇺🇸
Billings, Montana, United States
CoxHealth South Hospital
🇺🇸
Springfield, Missouri, United States
Saint Vincent Healthcare
🇺🇸
Billings, Montana, United States
Billings Clinic Cancer Center
🇺🇸
Billings, Montana, United States
Deaconess Medical Center
🇺🇸
Billings, Montana, United States
Glacier Oncology PLLC
🇺🇸
Kalispell, Montana, United States
Guardian Oncology and Center for Wellness
🇺🇸
Missoula, Montana, United States
Alegent Health Bergan Mercy Medical Center
🇺🇸
Omaha, Nebraska, United States
Creighton University Medical Center
🇺🇸
Omaha, Nebraska, United States
Ocean Medical Center
🇺🇸
Brick, New Jersey, United States
Cheshire Medical Center-Dartmouth-Hitchcock Keene
🇺🇸
Keene, New Hampshire, United States
Cooper Hospital University Medical Center
🇺🇸
Camden, New Jersey, United States
Jersey Shore Medical Center
🇺🇸
Neptune, New Jersey, United States
UMDNJ - New Jersey Medical School
🇺🇸
Newark, New Jersey, United States
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
🇺🇸
Mount Holly, New Jersey, United States
Riverview Medical Center/Booker Cancer Center
🇺🇸
Red Bank, New Jersey, United States
Virtua West Jersey Hospital Voorhees
🇺🇸
Voorhees, New Jersey, United States
Women's Cancer Care Associates LLC
🇺🇸
Albany, New York, United States
State University of New York Downstate Medical Center
🇺🇸
Brooklyn, New York, United States
Memorial Sloan-Kettering Cancer Center
🇺🇸
New York, New York, United States
Novant Health Presbyterian Medical Center
🇺🇸
Charlotte, North Carolina, United States
Good Samaritan Hospital Medical Center
🇺🇸
West Islip, New York, United States
Duke University Medical Center
🇺🇸
Durham, North Carolina, United States
Carolinas Medical Center/Levine Cancer Institute
🇺🇸
Charlotte, North Carolina, United States
Cone Health Cancer Center at Alamance Regional
🇺🇸
Burlington, North Carolina, United States
Annie Penn Memorial Hospital
🇺🇸
Reidsville, North Carolina, United States
Sanford Bismarck Medical Center
🇺🇸
Bismarck, North Dakota, United States
Summa Akron City Hospital/Cooper Cancer Center
🇺🇸
Akron, Ohio, United States
Altru Cancer Center
🇺🇸
Grand Forks, North Dakota, United States
North Coast Cancer Care-Clyde
🇺🇸
Clyde, Ohio, United States
Aultman Health Foundation
🇺🇸
Canton, Ohio, United States
Cleveland Clinic Cancer Center/Fairview Hospital
🇺🇸
Cleveland, Ohio, United States
Riverside Methodist Hospital
🇺🇸
Columbus, Ohio, United States
Mount Carmel Health Center West
🇺🇸
Columbus, Ohio, United States
Fremont Memorial Hospital
🇺🇸
Fremont, Ohio, United States
Wayne Hospital
🇺🇸
Greenville, Ohio, United States
Hillcrest Hospital Cancer Center
🇺🇸
Mayfield Heights, Ohio, United States
Toledo Clinic Cancer Centers-Oregon
🇺🇸
Oregon, Ohio, United States
The Toledo Hospital/Toledo Children's Hospital
🇺🇸
Toledo, Ohio, United States
Saint Vincent Mercy Medical Center
🇺🇸
Toledo, Ohio, United States
Upper Valley Medical Center
🇺🇸
Troy, Ohio, United States
University of Toledo
🇺🇸
Toledo, Ohio, United States
Mercy Saint Anne Hospital
🇺🇸
Toledo, Ohio, United States
Toledo Clinic Cancer Centers-Toledo
🇺🇸
Toledo, Ohio, United States
Toledo Community Hospital Oncology Program CCOP
🇺🇸
Toledo, Ohio, United States
Clinton Memorial Hospital
🇺🇸
Wilmington, Ohio, United States
Fulton County Health Center
🇺🇸
Wauseon, Ohio, United States
Greene Memorial Hospital
🇺🇸
Xenia, Ohio, United States
Cancer Care Associates-Midtown
🇺🇸
Tulsa, Oklahoma, United States
Bay Area Hospital
🇺🇸
Coos Bay, Oregon, United States
Tulsa Cancer Institute
🇺🇸
Tulsa, Oklahoma, United States
Penn State Milton S Hershey Medical Center
🇺🇸
Hershey, Pennsylvania, United States
Lehigh Valley Hospital-Cedar Crest
🇺🇸
Allentown, Pennsylvania, United States
Ephrata Cancer Center
🇺🇸
Ephrata, Pennsylvania, United States
University of Pennsylvania/Abramson Cancer Center
🇺🇸
Philadelphia, Pennsylvania, United States
Paoli Memorial Hospital
🇺🇸
Paoli, Pennsylvania, United States
Pennsylvania Hospital
🇺🇸
Philadelphia, Pennsylvania, United States
Chestnut Hill Health System
🇺🇸
Philadelphia, Pennsylvania, United States
Scranton Hematology Oncology
🇺🇸
Scranton, Pennsylvania, United States
Hematology and Oncology Associates of North East Pennsylvania
🇺🇸
Scranton, Pennsylvania, United States
WellSpan Health-York Hospital
🇺🇸
York, Pennsylvania, United States
Chattanooga's Program in Women's Oncology
🇺🇸
Chattanooga, Tennessee, United States
The Don and Sybil Harrington Cancer Center
🇺🇸
Amarillo, Texas, United States
Brooke Army Medical Center
🇺🇸
Fort Sam Houston, Texas, United States
Texas Tech University Health Sciences Center
🇺🇸
Lubbock, Texas, United States
Intermountain Medical Center
🇺🇸
Murray, Utah, United States
Utah Valley Regional Medical Center
🇺🇸
Provo, Utah, United States
McKay-Dee Hospital Center
🇺🇸
Ogden, Utah, United States
University of Vermont Medical Center
🇺🇸
Burlington, Vermont, United States
Providence Regional Cancer System-Centralia
🇺🇸
Centralia, Washington, United States
MultiCare Auburn Medical Center
🇺🇸
Auburn, Washington, United States
Capital Medical Center
🇺🇸
Olympia, Washington, United States
Virginia Mason CCOP
🇺🇸
Seattle, Washington, United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
🇺🇸
Seattle, Washington, United States
MultiCare Tacoma General Hospital
🇺🇸
Tacoma, Washington, United States
Northwest CCOP
🇺🇸
Tacoma, Washington, United States
Sacred Heart Hospital
🇺🇸
Eau Claire, Wisconsin, United States
Madigan Army Medical Center
🇺🇸
Tacoma, Washington, United States
Marshfield Clinic-Chippewa Center
🇺🇸
Chippewa Falls, Wisconsin, United States
Saint Vincent Hospital
🇺🇸
Green Bay, Wisconsin, United States
Marshfield Clinic Cancer Center at Sacred Heart
🇺🇸
Eau Claire, Wisconsin, United States
Green Bay Oncology at Saint Vincent Hospital
🇺🇸
Green Bay, Wisconsin, United States
Green Bay Oncology Limited at Saint Mary's Hospital
🇺🇸
Green Bay, Wisconsin, United States
Saint Mary's Hospital
🇺🇸
Green Bay, Wisconsin, United States
Bay Area Medical Center
🇺🇸
Marinette, Wisconsin, United States
Aurora BayCare Medical Center
🇺🇸
Green Bay, Wisconsin, United States
Medical Consultants Limited
🇺🇸
Milwaukee, Wisconsin, United States
Marshfield Clinic-Rice Lake Center
🇺🇸
Rice Lake, Wisconsin, United States
Green Bay Oncology - Oconto Falls
🇺🇸
Oconto Falls, Wisconsin, United States
Oconomowoc Memorial Hospital-ProHealth Care Inc
🇺🇸
Oconomowoc, Wisconsin, United States
Vince Lombardi Cancer Clinic-Sheboygan
🇺🇸
Sheboygan, Wisconsin, United States
Aurora West Allis Medical Center
🇺🇸
West Allis, Wisconsin, United States
Marshfield Clinic - Weston Center
🇺🇸
Weston, Wisconsin, United States
Iwate Medical University School of Medicine
🇯🇵
Morioka, Iwate, Japan
Tohoku University School of Medicine
🇯🇵
Sendai, Aoba-ku, Japan
Kure National Hospital
🇯🇵
Kure, Hiroshima, Japan
Keio University
🇯🇵
Shinjuku-ku, Tokyo, Japan
National Hospital Organization-Kobe Medical Center
🇯🇵
Kobe, Japan
Kagoshima City Hospital
🇯🇵
Kagoshima City, Kagoshima, Japan
Shikoku Cancer Center
🇯🇵
Matsuyama, Japan
Saitama Medical University International Medical Center
🇯🇵
Saitama, Japan
National Cancer Center Hospital
🇯🇵
Tokyo, Japan
Tottori University
🇯🇵
Tottori, Japan
Samsung Medical Center
🇰🇷
Seoul, Korea, Korea, Republic of
Asan Medical Center
🇰🇷
Seoul, Korea, Republic of
Korea Cancer Center Hospital
🇰🇷
Seoul, Korea, Republic of
Ajou University Hospital
🇰🇷
Suwon, Korea, Republic of
Kangnam Sacred Heart Hospital
🇰🇷
Youngdungpo-gu, Korea, Republic of
University of California Davis Comprehensive Cancer Center
🇺🇸
Sacramento, California, United States
Kaiser Permanente-South Sacramento
🇺🇸
Sacramento, California, United States
Kaiser Permanente - Sacramento
🇺🇸
Sacramento, California, United States
Saint Joseph Mercy Hospital
🇺🇸
Ann Arbor, Michigan, United States
Michigan Cancer Research Consortium CCOP
🇺🇸
Ann Arbor, Michigan, United States
Novant Health Oncology Specialists
🇺🇸
Winston-Salem, North Carolina, United States
Southeast Cancer Consortium-Upstate NCORP
🇺🇸
Winston-Salem, North Carolina, United States
Wake Forest University Health Sciences
🇺🇸
Winston-Salem, North Carolina, United States
Mercy Hospital
🇺🇸
Scranton, Pennsylvania, United States
Berkshire Hematology Oncology PC
🇺🇸
Pittsfield, Massachusetts, United States
University of Michigan Comprehensive Cancer Center
🇺🇸
Ann Arbor, Michigan, United States
Yale University
🇺🇸
New Haven, Connecticut, United States
Florida Hospital Orlando
🇺🇸
Orlando, Florida, United States
UF Cancer Center at Orlando Health
🇺🇸
Orlando, Florida, United States
Norton Hospital Pavilion and Medical Campus
🇺🇸
Louisville, Kentucky, United States
The James Graham Brown Cancer Center at University of Louisville
🇺🇸
Louisville, Kentucky, United States
Truman Medical Center
🇺🇸
Kansas City, Missouri, United States
Research Medical Center
🇺🇸
Kansas City, Missouri, United States
Saint Luke's Cancer Institute
🇺🇸
Kansas City, Missouri, United States
Saint Luke's Hospital of Kansas City
🇺🇸
Kansas City, Missouri, United States
Radiation Oncology Practice Corporation South
🇺🇸
Kansas City, Missouri, United States
Saint Joseph Health Center
🇺🇸
Kansas City, Missouri, United States
Radiation Oncology Practice Corporation - North
🇺🇸
Kansas City, Missouri, United States
University of North Carolina at Chapel Hill
🇺🇸
Chapel Hill, North Carolina, United States
Medical University of South Carolina
🇺🇸
Charleston, South Carolina, United States
Tulane University Health Sciences Center
🇺🇸
New Orleans, Louisiana, United States
Virginia Commonwealth University/Massey Cancer Center
🇺🇸
Richmond, Virginia, United States
Iowa Lutheran Hospital
🇺🇸
Des Moines, Iowa, United States
Oncare Hawaii Inc-POB II
🇺🇸
Honolulu, Hawaii, United States
University of Hawaii Cancer Center
🇺🇸
Honolulu, Hawaii, United States
Kapiolani Medical Center for Women and Children
🇺🇸
Honolulu, Hawaii, United States
University of Kentucky/Markey Cancer Center
🇺🇸
Lexington, Kentucky, United States
Queen's Medical Center
🇺🇸
Honolulu, Hawaii, United States
Tripler Army Medical Center
🇺🇸
Honolulu, Hawaii, United States
Oncare Hawaii Inc-Kuakini
🇺🇸
Honolulu, Hawaii, United States
The Cancer Center of Hawaii-Liliha
🇺🇸
Honolulu, Hawaii, United States
Mercy Capitol
🇺🇸
Des Moines, Iowa, United States
Medical Oncology and Hematology Associates-Laurel
🇺🇸
Des Moines, Iowa, United States
Mercy Medical Center - Des Moines
🇺🇸
Des Moines, Iowa, United States
Straub Clinic and Hospital
🇺🇸
Honolulu, Hawaii, United States
Iowa Methodist Medical Center
🇺🇸
Des Moines, Iowa, United States
Iowa Oncology Research Association CCOP
🇺🇸
Des Moines, Iowa, United States
Medical Oncology and Hematology Associates-Des Moines
🇺🇸
Des Moines, Iowa, United States
Dean Hematology and Oncology Clinic
🇺🇸
Madison, Wisconsin, United States
University of Wisconsin Hospital and Clinics
🇺🇸
Madison, Wisconsin, United States
Associates In Womens Health
🇺🇸
Wichita, Kansas, United States
Cancer Center of Kansas-Wichita Medical Arts Tower
🇺🇸
Wichita, Kansas, United States
Cancer Center of Kansas - Main Office
🇺🇸
Wichita, Kansas, United States
Via Christi Regional Medical Center
🇺🇸
Wichita, Kansas, United States
Wichita CCOP
🇺🇸
Wichita, Kansas, United States
Southwest Gynecologic Oncology Associates Inc
🇺🇸
Albuquerque, New Mexico, United States
University of New Mexico Cancer Center
🇺🇸
Albuquerque, New Mexico, United States
Grandview Hospital
🇺🇸
Dayton, Ohio, United States
Good Samaritan Hospital - Dayton
🇺🇸
Dayton, Ohio, United States
Samaritan North Health Center
🇺🇸
Dayton, Ohio, United States
Dayton CCOP
🇺🇸
Dayton, Ohio, United States
Veteran Affairs Medical Center
🇺🇸
Dayton, Ohio, United States
Illinois Oncology Research Association CCOP
🇺🇸
Peoria, Illinois, United States
Sanford USD Medical Center - Sioux Falls
🇺🇸
Sioux Falls, South Dakota, United States
Northern Rockies Radiation Oncology Center
🇺🇸
Billings, Montana, United States
Kaiser Permanente-Santa Teresa-San Jose
🇺🇸
San Jose, California, United States
Community Howard Regional Health
🇺🇸
Kokomo, Indiana, United States
Genesis Medical Center - West Campus
🇺🇸
Davenport, Iowa, United States
Cancer Center of Kansas - Winfield
🇺🇸
Winfield, Kansas, United States
North Coast Cancer Care
🇺🇸
Sandusky, Ohio, United States
Flower Hospital
🇺🇸
Sylvania, Ohio, United States
Cancer Center of Kansas - Pratt
🇺🇸
Pratt, Kansas, United States
Cancer Center of Kansas - Wellington
🇺🇸
Wellington, Kansas, United States

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Recruitment & Eligibility

Study & Design

Trial Locations

Instant Trial Alerts

Instant Trial Alerts